• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖会加速心血管衰老。

Obesity accelerates cardiovascular ageing.

作者信息

Ruperez Celia, Madeo Frank, de Cabo Rafael, Kroemer Guido, Abdellatif Mahmoud

机构信息

Department of Cardiology, Medical University of Graz, Auenbruggerplatz 15, Graz 8036, Austria.

Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria.

出版信息

Eur Heart J. 2025 Apr 8. doi: 10.1093/eurheartj/ehaf216.

DOI:10.1093/eurheartj/ehaf216
PMID:40197620
Abstract

A global obesity pandemic, coupled with an increasingly ageing population, is exacerbating the burden of cardiovascular disease. Indeed, clinical and experimental evidence underscores a potential connection between obesity and ageing in the pathogenesis of various cardiovascular disorders. This is further supported by the notion that weight reduction not only effectively reduces major cardiovascular events in elderly individuals but is also considered the gold standard for lifespan extension, in obese and non-obese model organisms. This review evaluates the intricate interplay between obesity and ageing from molecular mechanisms to whole organ function within the cardiovascular system. By comparatively analysing their characteristic features, shared molecular and cell biological signatures between obesity and ageing are unveiled, with the intent to shed light on how obesity accelerates cardiovascular ageing. This review also elaborates on how emerging metabolic interventions targeting obesity might protect from cardiovascular diseases largely through antagonizing key molecular mechanisms of the ageing process itself. In sum, this review aims to provide valuable insight into how understanding these interconnected processes could guide the development of novel and effective cardiovascular therapeutics for a growing aged population with a concerning obesity problem.

摘要

全球肥胖流行,加之人口老龄化加剧,正在加重心血管疾病的负担。事实上,临床和实验证据强调了肥胖与衰老在各种心血管疾病发病机制中的潜在联系。这一观点进一步得到以下观点的支持:体重减轻不仅能有效降低老年个体的主要心血管事件,而且在肥胖和非肥胖模式生物中,体重减轻也被视为延长寿命的黄金标准。本综述评估了肥胖与衰老在心血管系统内从分子机制到全器官功能的复杂相互作用。通过比较分析它们的特征,揭示了肥胖与衰老之间共同的分子和细胞生物学特征,旨在阐明肥胖如何加速心血管衰老。本综述还阐述了针对肥胖的新兴代谢干预措施如何主要通过对抗衰老过程本身的关键分子机制来预防心血管疾病。总之,本综述旨在提供有价值的见解,以说明理解这些相互关联的过程如何能够指导开发针对日益增多的、患有令人担忧的肥胖问题的老年人群的新型有效心血管疗法。

相似文献

1
Obesity accelerates cardiovascular ageing.肥胖会加速心血管衰老。
Eur Heart J. 2025 Apr 8. doi: 10.1093/eurheartj/ehaf216.
2
Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing.小而精——心血管疾病、代谢综合征和衰老过程中炎症反应的中心——微小 RNA。
Cardiovasc Res. 2012 Mar 15;93(4):605-13. doi: 10.1093/cvr/cvr268. Epub 2011 Oct 11.
3
Understanding the Impact of Obesity on Ageing in the Radiance of DNA Metabolism.理解 DNA 代谢光辉下肥胖对衰老的影响。
J Nutr Health Aging. 2023;27(5):314-328. doi: 10.1007/s12603-023-1912-1.
4
Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.交感神经系统作为与衰老和肥胖相关的心血管疾病的靶点。
Geroscience. 2019 Feb;41(1):13-24. doi: 10.1007/s11357-018-0048-5. Epub 2018 Dec 5.
5
Autolysosomal Dysfunction in Obesity-induced Metabolic Inflammation and Related Disorders.肥胖诱导的代谢性炎症及相关疾病中的自噬溶酶体功能障碍
Curr Obes Rep. 2025 May 14;14(1):43. doi: 10.1007/s13679-025-00638-8.
6
Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential.射血分数保留的心力衰竭中的热量限制及其模拟物:机制与治疗潜力
Cardiovasc Diabetol. 2025 Jan 18;24(1):21. doi: 10.1186/s12933-024-02566-8.
7
'Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue.“脂肪衰老”:衰老与肥胖具有与功能失调的脂肪组织相关的生物学特征。
J Physiol. 2016 Jun 15;594(12):3187-207. doi: 10.1113/JP271691. Epub 2016 May 10.
8
Anti-ageing interventions for the treatment of cardiovascular disease.用于治疗心血管疾病的抗衰老干预措施。
Cardiovasc Res. 2024 Aug 22. doi: 10.1093/cvr/cvae177.
9
Obesity and ageing: Two sides of the same coin.肥胖与衰老:同一问题的两个方面。
Obes Rev. 2020 Apr;21(4):e12991. doi: 10.1111/obr.12991. Epub 2020 Feb 5.
10
Feeding the critically ill obese patient: a systematic review protocol.为危重症肥胖患者提供营养支持:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):95-109. doi: 10.11124/jbisrir-2015-2458.

引用本文的文献

1
Circulating Lipid Profiles Indicate Incomplete Metabolic Recovery After Weight Loss, Suggesting the Need for Additional Interventions in Severe Obesity.循环脂质谱表明减肥后代谢未完全恢复,提示重度肥胖患者需要额外的干预措施。
Biomolecules. 2025 Aug 1;15(8):1112. doi: 10.3390/biom15081112.
2
Global burden of cancer attributable to high BMI (1990-2031): a multidimensional analysis based on GBD and Mendelian randomization.1990 - 2031年归因于高体重指数的全球癌症负担:基于全球疾病负担研究(GBD)和孟德尔随机化的多维度分析
Front Nutr. 2025 Aug 5;12:1618799. doi: 10.3389/fnut.2025.1618799. eCollection 2025.
3
Specific targeting of adipose tissue metabolism is superior to caloric restriction in treating obesity-related HFpEF.

本文引用的文献

1
Deubiquitinase USP25 Alleviates Obesity-Induced Cardiac Remodeling and Dysfunction by Downregulating TAK1 and Reducing TAK1-Mediated Inflammation.去泛素化酶USP25通过下调TAK1并减少TAK1介导的炎症来减轻肥胖诱导的心脏重塑和功能障碍。
JACC Basic Transl Sci. 2024 Aug 7;9(11):1287-1304. doi: 10.1016/j.jacbts.2024.06.001. eCollection 2024 Nov.
2
Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders.衰老细胞耗竭可缓解肥胖相关的代谢和心脏疾病。
Mol Metab. 2025 Jan;91:102065. doi: 10.1016/j.molmet.2024.102065. Epub 2024 Nov 16.
3
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity.
在治疗肥胖相关的射血分数保留的心力衰竭(HFpEF)方面,特异性靶向脂肪组织代谢优于热量限制。
Cardiovasc Diabetol. 2025 Jul 30;24(1):311. doi: 10.1186/s12933-025-02879-2.
4
Atrial Cardiomyopathy in Atrial Fibrillation: Mechanistic Pathways and Emerging Treatment Concepts.心房颤动中的心房心肌病:机制途径与新兴治疗理念
J Clin Med. 2025 May 7;14(9):3250. doi: 10.3390/jcm14093250.
替尔泊肽用于射血分数保留的心力衰竭合并肥胖症
N Engl J Med. 2025 Jan 30;392(5):427-437. doi: 10.1056/NEJMoa2410027. Epub 2024 Nov 16.
4
Measured and genetically predicted protein levels and cardiovascular diseases in UK Biobank and China Kadoorie Biobank.在英国生物库和中国科爱瑞生物库中测量和遗传预测的蛋白质水平与心血管疾病。
Nat Cardiovasc Res. 2024 Oct;3(10):1189-1198. doi: 10.1038/s44161-024-00545-6. Epub 2024 Sep 25.
5
Muscle matters: the effects of medically induced weight loss on skeletal muscle.肌肉的重要性:医学诱导体重减轻对骨骼肌的影响
Lancet Diabetes Endocrinol. 2024 Nov;12(11):785-787. doi: 10.1016/S2213-8587(24)00272-9. Epub 2024 Sep 9.
6
Obesity and cardiovascular disease: an ESC clinical consensus statement.肥胖与心血管病:ESC 临床共识声明
Eur Heart J. 2024 Oct 7;45(38):4063-4098. doi: 10.1093/eurheartj/ehae508.
7
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.司美格鲁肽在肥胖合并心力衰竭患者中的心血管结局:SELECT 试验的预先指定分析。
Lancet. 2024 Aug 24;404(10454):773-786. doi: 10.1016/S0140-6736(24)01498-3.
8
Targeting organ-specific mitochondrial dysfunction to improve biological aging.靶向器官特异性线粒体功能障碍以改善生物衰老。
Pharmacol Ther. 2024 Oct;262:108710. doi: 10.1016/j.pharmthera.2024.108710. Epub 2024 Aug 22.
9
Anti-ageing interventions for the treatment of cardiovascular disease.用于治疗心血管疾病的抗衰老干预措施。
Cardiovasc Res. 2024 Aug 22. doi: 10.1093/cvr/cvae177.
10
Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations.蛋白质组学衰老时钟可预测不同人群的死亡率和常见与年龄相关疾病的风险。
Nat Med. 2024 Sep;30(9):2450-2460. doi: 10.1038/s41591-024-03164-7. Epub 2024 Aug 8.